Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076842 · ClinicalTrials.gov registry record · Phase 4
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
A Phase 4 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT01076842: Completed Phase 4 study, sponsored by Novo Nordisk A/S.
NCT01076842 is a Phase 4 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01076842, a Phase 4 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two different kinds of diabetes medications, insulin detemir (Levemir) and exenatide (Byetta), in improving blood sugar levels with little or no weight gain in patients with type 2 diabetes who are not well controlled on two or more oral (by mouth) diabetes medications. Both medications are given by injection with a very small needle just below the surface of your skin (called subcutaneous injection). The medication that you inject will be in addition to your oral medications.
Interventions
- DRUG Insulin-Levemir
- DRUG Exenatide-Bayetta
- DRUG Insulin-Levemir and Exenatide-Bayetta
- DEVICE SenseWear Pro3® armband
- DEVICE DexCom CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
What the finished NCT01076842 record still lists
NCT01076842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 5 interventions - of which Insulin-Levemir is the first listed.
NCT01076842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01076842 about?
NCT01076842 is a clinical study titled "Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment". The purpose of this study is to compare the effectiveness of two different kinds of diabetes medications, insulin detemir (Levemir) and exenatide (Byetta), in improving blood sugar levels with little or no weight gain in patients with type 2 diabetes who are not well controlled on two or more oral (...
What is the current status of trial NCT01076842?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2008-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01076842?
The interventions under investigation include: Insulin-Levemir (DRUG), Exenatide-Bayetta (DRUG), Insulin-Levemir and Exenatide-Bayetta (DRUG), SenseWear Pro3® armband (DEVICE), DexCom CGM (DEVICE).
Who is sponsoring clinical trial NCT01076842?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01076842's enrollment target sits among peer trials
75 1002nd of 2000 higher than 974 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia